Association of polymorphisms in FLT3, EGFR, ALOX5, and NEIL3 with glioblastoma in the Han Chinese population

Medical Oncology

Volumn 30, Issue 4, 2013, Pages

  Jin, Tian Bo ^a,b   Li, Xiao Lan ^b   Yang, Hua ^b   Jiri, Mutu ^a   Shi, Xu Gang ^a   Yuan, Dong Ya ^a   Kang, Long Li ^a   Li, Shan Qu ^c  

^a XIZANG MINZU UNIVERSITY   (China)

^b NORTHWEST UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

ALOX5; Case control study; EGFR; FLT3; Glioblastoma (GBM); NEIL3; Tag single nucleotide polymorphism (tSNP)

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CD135 ANTIGEN; ENDONUCLEASE; EPIDERMAL GROWTH FACTOR RECEPTOR; ALOX5 PROTEIN, HUMAN; EGFR PROTEIN, HUMAN; FLJ10858 PROTEIN, HUMAN; FLT3 PROTEIN, HUMAN; GLYCOSIDASE;

ADULT; ALOX5 GENE; ARTICLE; CHINESE; CHROMOSOME; COMPUTER PROGRAM; CONTROLLED STUDY; EGFR GENE; FEMALE; FLT3 GENE; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GLIOBLASTOMA; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEIL3 GENE; POPULATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN; BRAIN TUMOR; GENETIC PREDISPOSITION; GENETICS;

ADULT; ARACHIDONATE 5-LIPOXYGENASE; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN NEOPLASMS; FEMALE; FMS-LIKE TYROSINE KINASE 3; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; N-GLYCOSYL HYDROLASES; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84891871264     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0718-1     Document Type: Article

References (17)

1. Lawson HC, Sampath P, Bohan E, Park MC, Hussain N, Olivi A, et al. Interstitial chemotherapy for malignant gliomas: the Johns Hopkins experience. J Neurooncol. 2007;83:61-70. (Pubitemid 46647166)
2. Rossetto M, Hallani SE, Sanson M. The Pro/Pro genotype at TP53 codon 72 polymorphism is associated with early onset glioblastoma. Cancer Genet. 2012;205:677.
3. Custodio AC, Almeida LO, Pinto GR, Santos MJ, Almeida JR, Clara CA, et al. GSTP1 Ile105Val polymorphism in astrocytomas and glioblastomas. Genet Mol Res. 2010;9:2328-34.
4. Gabriel S, Ziaugra L, Tabbaa D. SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet. 2009;Chapter 2:Unit 2.12. doi: 10.1002/0471142905.
5. Thomas RK, Baker AC, DeBiasi RM, Winckler W, LaFramboise T, Lin WM, et al. High-throughput oncogene mutation profiling in human cancer. Nat Genet. 2007;39:347-51. (Pubitemid 46328493)
6. 2 for comparison of 2 independent examples. Cesk Zdrav. 1964;12:613-9.
7. Bland JM, Altman DG. Statistics notes. The odds ratio. Br Med J. 2000;320:1468. (Pubitemid 30311684)
8. Sole X, Guino E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006;22:1928-9. (Pubitemid 44283043)
9. Patyna S, Laird AD, Mendel DB, O'farrell AM, Liang C, Guan H, et al. SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity. Mol Cancer Ther. 2006;5:1774-82. (Pubitemid 44323245)
10. Ravandi F, Kantarjian H, Faderl S, Garcia-Manero G, O'Brien S, Koller C, et al. Outcome of patients with FLT3-mutated acute myeloid leukemia in first relapse. Leuk Res. 2010;34:752-6.
11. Armstrong SA, Mabon ME, Silverman LB, Li A, Gribben JG, Fox EA, et al. FLT3 mutations in childhood acute lymphoblastic leukemia. Blood. 2004;103:3544-6. (Pubitemid 38525690)
12. Scagliotti GV, Selvaggi G, Novello S, Hirsch FR. The biology of epidermal growth factor receptor in lung cancer. Clin Cancer Res. 2004;10:4227s-32s. (Pubitemid 38812451)
13. Hou WG, Ai WB, Bai XG, Dong HL, Li Z, Zhang YQ, et al. Genetic variation in the EGFR gene and the risk of glioma in a Chinese Han population. PLoS One. 2012;7(5):e37531.
14. Perez CA, Chen H, Shyr Y, Courtney R, Zheng W, Cai Q, et al. The EGFR polymorphism rs884419 is associated with freedom recurrence in patients with resected prostate cancer. J Urol. 2010;183:2062-9.
15. Heimberger AB, Suki D, Yang D, Shi WM, Aldape K. The natural history of EGFR and EGFRvIII in glioblastoma patients. J Transl Med. 2005;3:38. (Pubitemid 41582047)
16. Ishii K, Zaitsu M, Yonemitsu N, Kan Y, Hamasaki Y, Matsuo M. 5-Lipoxygenase pathway promotes cell proliferation in human glioma cell lines. Clin Neuropathol. 2009;28:445-52.
17. Wallace SS, Murphy DL, Sweasy JB. Base excision repair and cancer. Cancer Lett. 2012;327:73-89.